Skip to main content
. 2020 May 8;96:291–293. doi: 10.1016/j.ijid.2020.05.021

Table 1.

Association between the final outcome and the selected independent variables.

Independent variables Total (302) Final outcome
p-Value*
Recovery (237) Death (65)
Patient age, years 67.0 (57.0–77.0) 64.0 (54.0–73.3) 77.0 (70.5–81.0) <0.0001
Patient sex
 Male 194 (64.2) 144 (47.7) 50 (16.6) 0.0162
 Female 108 (35.8) 93 (30.8) 15 (5.0)
Brixia score 8.0 (5.0–11.0) 7.0 (4.0–10.0) 11.0 (9–13.0) <0.0001
Hypertension
 Yes 154 (51.0) 112 (37.1) 42 (13.9) 0.0133
 No 148 (49.0) 125 (41.4) 23 (7.6)
Cardiovascular disease
 Yes 126 (41.7) 84 (27.8) 42 (13.9) <0.0001
 No 176 (58.3) 153 (50.7) 23 (7.6)
Diabetes
 Yes 38 (12.6) 25 (8.3) 13 (4.3) 0.0422
 No 264 (87.4) 212 (70.2) 52 (17.2)
Chronic obstructive/restrictive lung disease
 Yes 44 (14.6) 31 (10.3) 13 (4.3) 0.1620
 No 258 (85.4) 206 (68.2) 52 (17.2)
Oncological history within the past 5 years
 Yes 56 (18.5) 36 (11.9) 20 (6.6) 0.0043
 No 246 (81.5) 201 (66.6) 45 (14.9)
T/D inducing immunosupppresion
 Yes 98 (32.5) 62 (20.5) 36 (11.9) <0.0001
 No 204 (67.5) 175 (57.9) 29 (9.6)

Data are presented as numbers (%) or medians (interquartile range); *p-values obtained by Mann–Whitney U test or chi-square test; T/D, therapy or disease.